Current guidelines recommend consolidation with autologous stem cell transplantation (autoSCT) after induction chemotherapy for most patients with peripheral T-cell lymphoma (PTCL). This assumption is based on five prospective phase II studies, three of which included <50 patients with limited follow-up. Here we present the final analysis of the prospective German study. The treatment regimen consisted of four to six cycles of CHOP chemotherapy followed by mobilizing therapy and stem cell collection. Patients in complete remission (CR) or partial remission (PR) underwent myeloablative chemo(radio)therapy and autoSCT. From January 2001 to July 2010, 111 patients were enrolled in the study. The main subgroups were PTCL not specified (n=42) an...
AbstractThe peripheral T cell lymphomas (PTCL) carry a worse prognosis compared to B cell non-Hodgki...
Background: The role of autologous stem cell transplantation (ASCT) in the first complete remission ...
peer reviewedBackground: Peripheral T-cell lymphoma (PTCL) remains a therapeutic challenge. Due to t...
Current guidelines recommend consolidation with autologous stem cell transplantation (autoSCT) after...
Peripheral T-cell lymphomas (PTCL) are a heterogeneous group of rare lymphoid malignancies that most...
Peripheral T-cell lymphomas (PTCLs) are a heterogeneous group of rare diseases, characterized by an ...
Peripheral T-cell lymphomas (PTCL) are a heterogeneous group of rare lymphoid malignancies that most...
Outcome of systemic peripheral T-cell lymphomas (PTCL) is unsatisfactory and no controlled clinical ...
Autologous stem-cell transplantation; Chemotherapy; T-cell lymphomaTrasplante autólogo de células ma...
PURPOSE: Systemic peripheral T-cell lymphomas (PTCLs) respond poorly to conventional therapy. To eva...
International audienceBackground: Peripheral T-cell lymphoma (PTCL) remains a therapeutic challenge....
peer reviewedBackground: Peripheral T cell lymphomas form a heterogeneous group with a usually disma...
We report the results of two prospective phase II studies investigating the role of high-dose sequen...
Abstract BACKGROUND: Peripheral T-cell lymphoma (PTCL) is a heterogeneous group of aggressive lymp...
This report is a retrospective analysis of 65 patients with peripheral T cell lymphoma (PTCL), who u...
AbstractThe peripheral T cell lymphomas (PTCL) carry a worse prognosis compared to B cell non-Hodgki...
Background: The role of autologous stem cell transplantation (ASCT) in the first complete remission ...
peer reviewedBackground: Peripheral T-cell lymphoma (PTCL) remains a therapeutic challenge. Due to t...
Current guidelines recommend consolidation with autologous stem cell transplantation (autoSCT) after...
Peripheral T-cell lymphomas (PTCL) are a heterogeneous group of rare lymphoid malignancies that most...
Peripheral T-cell lymphomas (PTCLs) are a heterogeneous group of rare diseases, characterized by an ...
Peripheral T-cell lymphomas (PTCL) are a heterogeneous group of rare lymphoid malignancies that most...
Outcome of systemic peripheral T-cell lymphomas (PTCL) is unsatisfactory and no controlled clinical ...
Autologous stem-cell transplantation; Chemotherapy; T-cell lymphomaTrasplante autólogo de células ma...
PURPOSE: Systemic peripheral T-cell lymphomas (PTCLs) respond poorly to conventional therapy. To eva...
International audienceBackground: Peripheral T-cell lymphoma (PTCL) remains a therapeutic challenge....
peer reviewedBackground: Peripheral T cell lymphomas form a heterogeneous group with a usually disma...
We report the results of two prospective phase II studies investigating the role of high-dose sequen...
Abstract BACKGROUND: Peripheral T-cell lymphoma (PTCL) is a heterogeneous group of aggressive lymp...
This report is a retrospective analysis of 65 patients with peripheral T cell lymphoma (PTCL), who u...
AbstractThe peripheral T cell lymphomas (PTCL) carry a worse prognosis compared to B cell non-Hodgki...
Background: The role of autologous stem cell transplantation (ASCT) in the first complete remission ...
peer reviewedBackground: Peripheral T-cell lymphoma (PTCL) remains a therapeutic challenge. Due to t...